Abstract:AQ4N (1,4-bis([2-(dimethylamino-N-oxide)ethyl]amino)5,8-dihydroxy- anthracene-9,10-dione) is a novel alkylaminoanthraquinone N-oxide which, on reduction, forms a stable DNA affinic cytotoxic compound AQ4. The in vivo anti-tumour efficacy of AQ4N was investigated in B6D2F1 mice bearing the T50/80 mammary carcinoma. The effect of the drug was evaluated in combination with hypobaric hypoxia and with radiation (single and multiple fractions). Systemic toxicity was assessed by weight loss post treatment. This was low for AQ4N and was less than that obtained with the bioreductive drugs, RSU 1069 (1-[3-aziridinyl-2-hydroxypropyl]-2-nitroimidazole) and SR 4233 (Tirapazamine, 3-amino-1,2,4-benzotriazine-1,4-dioxide). The anti-tumour effect of AQ4N was potentiated in vivo by combination with hypobaric hypoxia with a dose enhancement ratio of 5.1. This is consistent with the proposal that AQ4N was reduced in vivo to AQ4, resulting in enhanced anti-tumour toxicity. When AQ4N (200 mg kg-1) was combined with single dose radiation (12 Gy) the drug was shown to have an additive interaction with radiation. This was obtained even if the drug was administered from 4 days before to 6 h after radiation treatment. Equivalent anti-tumour activity was also shown when both AQ4N (200 mg kg-1) and radiation (5 x 3 Gy) were administered in fractionated schedules. In conclusion, AQ4N shows significant potential as a bioreductive drug for combination with fractionated radiotherapy.

A large-scale synthesis of the bioreductive drug 1,4-bis{[2-(dimethylamino)ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione bis-N-oxide (AQ4N)

Improved Synthetic Process for 3-Benzyloxy-4-n-butylaniline Hydrochloride

An Enzymatic Oxidation Cascade Converts Δ-Thiolactone Anthracene to Anthraquinone in the Biosynthesis of Anthraquinone-Fused Enediynes

Metal-free Nucleophilic 7,8-Dearomatization of Quinolines: Spiroannulation of Aminoquinoline Protected Amino Acids

Selective Removal of Aminoquinoline Auxiliary by IBX Oxidation

AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo

Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy

Scalable total synthesis of (+)-aniduquinolone A and its acid-catalyzed rearrangement to aflaquinolones

Scalable Total Synthesis of Aflaquinolone I

A Convenient and Efficient Synthesis of 2-Acetyl-5,8-dimethoxy-1,4-naphthoquinone

Synthesis of 1-Allyl-6-chloro-7-methyl-1,4-dihydroquinoxaline-2,3-dione

A New Efficient Route for the Synthesis of 4,4′,6,6′-Tetra-(azido)azo-1,3,5-triazine

The synthesis of afloquanone

Synthesis of High-Nitrogen Compound of 4,4′,6,6′-Tetra(azido)azo-1,3,5-triazine

Azaanthraquinone Assembly From N-Propargylamino Quinone Via A Au(I)-Catalyzed 6-Endo-Dig Cycloisomerization

Synthesis of N-(3-chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl) oxy) quinazolin-4-amine

A PRACTICAL PROCEDURE FOR THE SYNTHESIS OF 3-((E)-5-(2,3,4,5-TETRAMETHOXY-6-METHYLPHENYL)-3METHYLPENT-3-ENYL)-2,2-DIMETHYLOXIRANE

CuCl2-promoted 6-Endo-dig Chlorocyclization and Oxidative Aromatization Cascade: Efficient Construction of 1-Azaanthraquinones from N-propargylaminoquinones.

Copper(ii)-catalyzed and Acid-Promoted Highly Regioselective Oxidation of Tautomerizable C(sp3)–H Bonds Adjacent to 3,4-Dihydroisoquinolines Using Air (O2) As a Clean Oxidant

Concise Access to Naphthalene Building Blocks for Naphthylisoquinoline Alkaloid Synthesis via Transition‐Metal Catalysis

Building a Quaternary Stereogenic Center on Dihydroazaindole Carboxylic Acid through Scalable Process Development